DTIL Precision BioSciences Inc

USD 13.56 0.58 4.468413
Icon

Precision BioSciences Inc (DTIL) Stock Analysis and Price Targets

COMMON STOCK | Biotechnology | NSD
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 13.56

+0.58 (+4.47)%

USD 0.07B

0.19M

N/A

N/A

Icon

DTIL

Precision BioSciences Inc (USD)
COMMON STOCK | NSD
USD 13.56
0.00 0
Take a Tour
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 0.07B

N/A

USD 13.56

Precision BioSciences Inc (DTIL) Stock Forecast

N/A

Based on the Precision BioSciences Inc stock forecast from 0 analysts, the average analyst target price for Precision BioSciences Inc is not available over the next 12 months. Precision BioSciences Inc’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Precision BioSciences Inc is Bearish, which is based on 1 positive signals and 7 negative signals. At the last closing, Precision BioSciences Inc’s stock price was USD 13.56. Precision BioSciences Inc’s stock price has changed by +13.38% over the past week, -26.94% over the past month and -41.07% over the last year.

No recent analyst target price found for Precision BioSciences Inc
No recent average analyst rating found for Precision BioSciences Inc

Company Overview Precision BioSciences Inc

Precision BioSciences, Inc., a clinical stage gene editing company, develops ex vivo allogeneic chimeric antigen receptor (CAR) T immunotherapies and in vivo therapies for genetic and infectious diseases in the United States. The company offers ARCUS, a genome editing platform to...Read More

302 East Pettigrew Street, Durham, NC, United States, 27701

115

December

USD

USA

Adjusted Closing Price for Precision BioSciences Inc (DTIL)

Loading...

Unadjusted Closing Price for Precision BioSciences Inc (DTIL)

Loading...

Share Trading Volume for Precision BioSciences Inc Shares

Loading...

Compare Performance of Precision BioSciences Inc Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for DTIL

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To Precision BioSciences Inc (Sector: Biotechnology )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
VRTX
Vertex Pharmaceuticals Inc +0.69 (+0.17%) USD107.38B 29.93 21.06

ETFs Containing DTIL

Symbol Name DTIL's Weight Expense Ratio Price(Change) Market Cap
no data

Frequently Asked Questions About Precision BioSciences Inc (DTIL) Stock

Stock Target Advisor's fundamental analysis for Precision BioSciences Inc's stock is Bearish.

Unfortunately we do not have enough data on DTIL's stock to indicate if its a good dividend stock.

Unfortunately we do not have enough data on DTIL's stock to indicate what its average analyst target is.

DTIL stock's Price/Earning ratio is 4.99. Our analysis grades DTIL stock's Price / Earning ratio at F. This means that DTIL stock's Price/Earning ratio is above 48% of the stocks in the Biotechnology sector in the NSD exchange. Based on this DTIL may be fairly valued for its sector

The last closing price of DTIL's stock was USD 13.56.

The most recent market capitalization for DTIL is USD 0.07B.

Unfortunately we do not have enough analyst data on DTIL's stock to indicate whether its price will go up or not.

We can't find any ETFs which contains Precision BioSciences Inc's stock.

As per our most recent records Precision BioSciences Inc has 115 Employees.

Precision BioSciences Inc's registered address is 302 East Pettigrew Street, Durham, NC, United States, 27701. You can get more information about it from Precision BioSciences Inc's website at https://www.precisionbiosciences.com.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...